250 related articles for article (PubMed ID: 1664330)
21. Effects of intrathecally injected histamine receptor antagonists on the antinociception induced by morphine, beta-endorphin, and U50, 488H administered intrathecally in the mouse.
Suh HW; Song DK; Choi YS; Kim YH
Neuropeptides; 1996 Oct; 30(5):485-90. PubMed ID: 8923512
[TBL] [Abstract][Full Text] [Related]
22. Effect of 7-nitroindazole on tolerance to morphine, U-50,488H and [D-Pen2, D-Pen5] enkephalin in mice.
Bhargava HN; Cao YJ; Zhao GM
Peptides; 1997; 18(6):797-800. PubMed ID: 9285927
[TBL] [Abstract][Full Text] [Related]
23. The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action.
Czlonkowski A; Millan MJ; Herz A
Eur J Pharmacol; 1987 Oct; 142(1):183-4. PubMed ID: 2826175
[No Abstract] [Full Text] [Related]
24. Effects of ibogaine on the development of tolerance to antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
Cao YJ; Bhargava HN
Brain Res; 1997 Mar; 752(1-2):250-4. PubMed ID: 9106464
[TBL] [Abstract][Full Text] [Related]
25. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
Bhargava HN; Gulati A; Ramarao P
J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
[TBL] [Abstract][Full Text] [Related]
26. Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine.
Suzuki T; Narita M; Takahashi Y; Misawa M; Nagase H
Eur J Pharmacol; 1992 Mar; 213(1):91-7. PubMed ID: 1499660
[TBL] [Abstract][Full Text] [Related]
27. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
Miaskowski C; Levine JD
Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
[TBL] [Abstract][Full Text] [Related]
28. Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia.
Takahashi M; Senda T; Tokuyama S; Kaneto H
Jpn J Pharmacol; 1990 Aug; 53(4):487-94. PubMed ID: 2170723
[TBL] [Abstract][Full Text] [Related]
29. Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats.
Fukagawa Y; Katz JL; Suzuki T
Eur J Pharmacol; 1989 Oct; 170(1-2):47-51. PubMed ID: 2558895
[TBL] [Abstract][Full Text] [Related]
30. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
Herrero JF; Headley PM
Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
[TBL] [Abstract][Full Text] [Related]
31. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
32. Footshock- and psychological-stress prevent the development of tolerance to spinal but not supraspinal morphine.
Takahashi M; Kaneto H
Jpn J Pharmacol; 1991 Jun; 56(2):121-6. PubMed ID: 1652662
[TBL] [Abstract][Full Text] [Related]
33. Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice.
Thorat SN; Veeranna ; Reddy PL; Bhargava HN
Brain Res; 1993 Jul; 615(2):191-8. PubMed ID: 8395957
[TBL] [Abstract][Full Text] [Related]
34. Antinociceptive effects of morphine and U-50,488H on vaginal distension in the anesthetized rat.
Friese N; Diop L; Lambert C; Rivière PJ; Dahl SG
Life Sci; 1997; 61(16):1559-70. PubMed ID: 9353165
[TBL] [Abstract][Full Text] [Related]
35. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
36. The effect of U-50,488H, a kappa-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat.
Bhargava HN; Matwyshyn G; Ramarao P
Gen Pharmacol; 1991; 22(3):429-34. PubMed ID: 1651266
[TBL] [Abstract][Full Text] [Related]
37. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.
Takemori AE; Ho BY; Naeseth JS; Portoghese PS
J Pharmacol Exp Ther; 1988 Jul; 246(1):255-8. PubMed ID: 2839664
[TBL] [Abstract][Full Text] [Related]
38. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse.
Xu JY; Tseng LF
Eur J Pharmacol; 1994 Sep; 262(3):223-31. PubMed ID: 7813587
[TBL] [Abstract][Full Text] [Related]
39. Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.
Welch SP
J Pharmacol Exp Ther; 1993 May; 265(2):633-40. PubMed ID: 8388455
[TBL] [Abstract][Full Text] [Related]
40. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
